Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

View/Open

Accepted version (220.4Kb)

Date

2020-04

ICR Author

Hall, Emma

Lewis, Rebecca

Author

Birtle, A

Johnson, M

Chester, J

Jones, R

Dolling, D

Bryan, RT

Harris, C

Winterbottom, A

Blacker, A

Catto, JWF

Chakraborti, P

Donovan, JL

Elliott, PA

French, A

Jagdev, S

Jenkins, B

Keeley, FX

Kockelbergh, R

Powles, T

Wagstaff, J

Wilson, C

Todd, R

Lewis, R

Hall, E

Show allShow less

Type

Journal Article

Metadata

Show full item record

URI

https://repository.icr.ac.uk/handle/internal/4104

DOI

https://doi.org/10.1016/s0140-6736(20)30415-3

Collections

• Clinical Studies

Research team

Clinical Trials & Statistics Unit

ICR-CTSU Urology and Head and Neck Trials Team

Language

eng

Date accepted

2020-02-12

License start date

2020-04

Citation

The Lancet, 2020, 395 (10232), pp. 1268 - 1277

Publisher

Elsevier BV